180 related articles for article (PubMed ID: 17404490)
1. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
Tanaka Y; Suzuki K; Saito K
Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
Kitahara K; Kawai S
Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.
Yocum DE; Furst DE; Kaine JL; Baldassare AR; Stevenson JT; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
Arthritis Rheum; 2003 Dec; 48(12):3328-37. PubMed ID: 14673984
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
5. A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis.
Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2005 Jan; 54(1):1-9. PubMed ID: 15723198
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.
Suzuki K; Saito K; Tsujimura S; Nakayamada S; Yamaoka K; Sawamukai N; Iwata S; Nawata M; Nakano K; Tanaka Y
J Rheumatol; 2010 Mar; 37(3):512-20. PubMed ID: 20080907
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
8. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
9. Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients.
Kawai S; Yamamoto K
Rheumatology (Oxford); 2006 Apr; 45(4):441-4. PubMed ID: 16263777
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
11. [Joint destruction and its repair in rheumatoid arthritis].
Kohsaka H
Clin Calcium; 2009 Mar; 19(3):317-23. PubMed ID: 19252241
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus treatment for rheumatoid arthritis patients undergoing hemodialysis.
Yamashita M; Natsumeda M; Takasugi K; Ueno A; Ezawa K; Ezawa K
Mod Rheumatol; 2008; 18(3):296-300. PubMed ID: 18322644
[TBL] [Abstract][Full Text] [Related]
13. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus: in patients with rheumatoid arthritis.
Curran MP; Perry CM
Drugs; 2005; 65(7):993-1001; discussion 1002-3. PubMed ID: 15892590
[TBL] [Abstract][Full Text] [Related]
15. [Tacrolimus for therapy of rheumatoid arthritis].
Harigai M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():508-12. PubMed ID: 15799408
[No Abstract] [Full Text] [Related]
16. [Assessment of joint structure in patients with rheumatoid arthritis].
Tanaka Y
Clin Calcium; 2013 Mar; 23(3):409-17. PubMed ID: 23445895
[TBL] [Abstract][Full Text] [Related]
17. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients.
Hirohata S; Yanagida T; Tomita T; Yoshikawa H
Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788
[TBL] [Abstract][Full Text] [Related]
18. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis.
Yokota K; Akiyama Y; Asanuma Y; Miyoshi F; Sato K; Mimura T
Rheumatol Int; 2009 Feb; 29(4):459-61. PubMed ID: 18802706
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations of Czech Rheumatological Society for the treatment of rheumatoid arthritis. Efficacy and treatment strategies].
Becvár R; Vencovský J; Nĕmec P; Suchý D; Procházková L; Pavelka K;
Vnitr Lek; 2008 Jan; 54(1):84-99. PubMed ID: 18390121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
